You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 5,952,316


✉ Email this page to a colleague

« Back to Dashboard


Title: 2-amino-1,3-propanediol compound and immunosuppressant
Abstract:2-Amino-1,3-propanediol compounds of the formula (I) ##STR1## wherein R is an optionally substituted straight- or branched carbon chain, an optionally substituted aryl, an optionally substituted cycloalkyl or the like, and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different and each is a hydrogen, an alkyl, an aralkyl, an acyl or an alkoxycarbonyl, pharmaceutically acceptable salts thereof and immunosuppressants comprising these compounds as active ingredients. The 2-amino-1,3-propanediol compounds of the present invention show immunosuppressive action and are useful for suppressing rejection in organ or bone marrow tranplantation, prevention and treatment of autoimmune diseases or as reagents for use in medicinal and pharmaceutical fields.
Inventor(s): Fujita; Tetsuro (Muko, JP), Sasaki; Shigeo (Kobe, JP), Yoneta; Masahiko (Kobe, JP), Mishina; Tadashi (Iruma, JP), Adachi; Kunitomo (Iruma, JP), Chiba; Kenji (Iruma, JP)
Assignee: Yoshitomi Pharmaceutical Industries, Ltd. (Osaka, JP) Taito Co., Ltd. (Tokyo, JP)
Filing Date:Aug 14, 1997
Application Number:08/911,602
Claims:1. A pharmaceutical composition which comprises an immunosuppressing effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

2. A method for immunosuppression of an immune system of a mammal, which comprises administering to a mammal in need thereof an immunosuppressing effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

3. A method for suppression of rejection in an organ or bone marrow transplantation in a mammal, which comprises administering to a mammal in need thereof a rejection suppressing effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

4. A method for prevention or treatment of autoimmune disease, which comprises administering to a mammal in need thereof a therapeutically effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

5. The method according to claim 4, wherein the autoimmune disease is rheumatoid arthritis.

6. A method for prevention or treatment of psoriasis or atopic dermatitis, which comprises administering to a mammal in need thereof a therapeutically effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

7. A method for prevention or treatment of bronchial asthma or pollinosis, which comprises administering to a mammal in need thereof a therapeutically effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

8. A method for prevention or treatment of Behcet's disease, which comprises administering to a mammal in need thereof a therapeutically effective amount of 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride in combination with an immunosuppressant selected from the group consisting of cyclosporin, azathioprine, a steroid and tacrolimus [FK-506].

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.